PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs

Cell

Volumn 99, Issue 3, 1999, Pages 335-345

  He, Tong Chuan ^a   Chan, Timothy A ^a   Vogelstein, Bert ^b   Kinzler, Kenneth W ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RNA; SULINDAC; APC PROTEIN; CELL RECEPTOR; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; T CELL FACTOR 4; T CELL FACTOR PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA BINDING; EMBRYO; GENE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; CELL CULTURE; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BETA CATENIN; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; GENES, APC; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SULINDAC; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033615352     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81664-5     Document Type: Article

References (61)

1. Ahnen, D.J. (1998). Colon cancer prevention by NSAIDs: what is the mechanism of action? Eur. J. Surg. Suppl. 582, 111-114.
2. Amri, E.Z., Bonino, F., Ailhaud, G., Abumrad, N.A., and Grimaldi, P.A. (1995). Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome prolifera-tor-activated receptors. J. Biol. Chem. 270, 2367-2371.
3. Behiens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642.
4. Brockman, J.A., Gupta, R.A., and Dubois, R.N. (1998). Activation of PPARγ leads to inhibition of anchorage-independent growth of human CRC cells. Gastroenterology 115, 1049-1055.
5. Chan, T.A., Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1998). Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA 95, 681-686.
6. Charalambous, D., Skinner, S.A., and O'Brien, P.E. (1998). Sulindac inhibits colorectal tumour growth, but not prostaglandin synthesis in the rat. J. Gastroenterol. Hepatol. 13, 1195-1200.
7. Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N., and Dove, W. (1993). Genetic identification of Mom-1, a major modifier locus affecting M in-induced intestinal neoplasia in the mouse. Cell 75, 631-639.
8. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, P.M., Ferrenbach, S., and DuBois, R.N. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188.
9. Elder, D.J., Halton, D.E., Hague, A., and Paraskeva, C. (1997). Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res. 3, 1679-1683.
10. Forman, B.M., Chen, J., and Evans, R.M. (1997). Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors a and 5. Proc. Natl. Acad. Sci. USA 94, 4312-4317.
11. Gearing, K.L., Gottlicher, M., Teboul, M., Widmark, E., and Gustafsso n, J.A. (1993). Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 90, 1440-1444.
12. Hanif, R., Pittas, A., Feng, Y., Koutsos, M.I., Qiao, L., Staiano-Coico, L., Shift, S. I., and Rigas, B. (1996). Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52, 237-245.
13. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1998a). Identification of c-MYC as a target of the APC pathway. Science 287, 1509-1512.
14. He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B. (1998b). A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514.
15. Jow, L., and Mukherjee, R. (1995). The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR a and thyroid hormone receptors. J. Biol. Chem. 270, 3836-3840.
16. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A.G., Wahli, W., Meier, C.A., and Desvergne, B. (1997). DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272, 25252-25259.
17. Kastner, P., Mark, M., and Chambon, P. (1995). Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83, 859-869.
18. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., and Wahli, W. (1993). Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 90, 2160-2164.
19. Kinzler, K.W., and Vogelstein, B. (1996). Lessons from hereditary colon cancer. Cell 87, 159-170.
20. Kliewer, S.A., Sundseth, S.S., Jones, S.A., Brown, P.J., Wisely, G.B., Koble, C.S., Devchand, P., Wahli, W., Willson, T.M., Lenhard, J.M., and Lehmann, J.M. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and y. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
21. Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997). Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-1787.
22. Lefebvre, A.M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.C., Geboes, K., Briggs, M., Heyman, R., and Auwerx, J. (1998). Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat. Med. 4, 1053-1057.
23. Lehmann, J.M., Lenhard, J.M., Oliver, B.B., Ringold, G.M., and Kliewer, S.A. (1997). Peroxisome proliferator-activated receptors a and γ are activated by indomethacin and other non-steroidal antiinflammatory drugs. J. Biol. Chem. 272, 3406-3410.
24. Lemberger, T., Desvergne, B., and Wahli, W. (1996). Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12, 335-363.
25. Lim, H., Gupta, R.A., Ma, W., Paria, B.C., Moller, D.E., Morrow, J.D., DuBois, R.N., Trzaskos, J.M., and Dey, S.K. (1999). Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 13, 1561-1574.
26. Min-induced intestinal neoplasia. Cell 87, 957-966.
27. Mahmoud, N.N., Boolbol, S.K., Dannenberg, A.J., Mestre, J.R., Bilinski, R.T., Martucci, C., Newmark, H.L., Chadburn, A., and Bertagnolli, M.M. (1998). The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 19, 87-91.
28. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
29. Mann, B., Gelos, M., Siedow, A., Hanski, M.L., Gratchev, A., llyas, M., Bodmer, W.F., Moyer, M.P., Riecken, E.O., Buhr, H.J., and Hanski, C. (1999). Target genes of β-catenin-T cell-factor/lymphoid-enhancerfactor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA 96, 1603-1608.
30. Molenaar, M., van de Wetering, M., Oosterwegel, M., PetersonMaduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996). XTcf-3 transcription factor mediates βcatenininduced axis formation in Xenopus embryos. Cell 86, 391-399.
31. Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1996). Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 93, 7950-7954.
32. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K.W. (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790.
33. Munemitsu, S., Albert, l., Souza, B., Rubinfeld, B., and Polakis, P. (1995). Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA 92, 3046-3050.
34. Narisawa, T., Hermanek, P., Habs, M., and Schmahl, D. (1984). Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J. Cancer Res. Clin. Oncol. 108, 239-242.
35. Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F., and Taketo, M.M. (1996). Suppression of intestinal polyposis in APC (716) knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809.
36. Pennica, D., Swanson, T.A., Welsh, J.W., Roy, M.A., Lawrence, D.A., Lee, J., Brush, J., Taneyhill, L.A., Deuel, B., Lew, M., et al. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95, 14717-14722.
37. Piazza, G.A., Rahm, A.L.K., Krutzsch, M., Sperl, G., Paranka, N.S., Gross, P.H., Brendel, K., Burt, R.W., Alberts, D.S., Pamukcu, R., and Ahnen, D.J. (1995). Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55, 31 ID3116.
38. Piazza, G.A., Alberts, D.S., Hixson, L.J., Paranka, N.S., Li, H., Finn, T., Bogert, C., Guillen, J.M., Brendel, K., Gross, P.H., et al. (1997). Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 57, 2909-2915.
39. Prescott, S.M., and White, R.L. (1996). Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87, 783-786.
40. Reddy, B.S., Kawamori, T., Lubet, R.A., Steele, V.E., Kelloff, G.J., and Rao, C.V. (1999). Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res. 59, 3387-3391.
41. Rubinfeld, B., Souza, B., Albert, l., Muller, O., Chamberlain, S.H., Masiarz, F.R., Munemitsu, S., and Polakis, P. (1993). Association of the ARC gene product with β-catenin. Science 262, 1731-1734.
42. Rubinfeld, B., Robbins, P., EI-Gamil, M., Albeit, I., Porfiri, E., and Polakis, P. (1997). Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792.
43. Saez, E., Tontonoz, P., Nelson, M.C., Alvarez, J.G., Ming, U.T., Baird, S.M., Thomazy, V.A., and Evans, R.M. (1998). Activators of the nuclear receptor PPAR γ enhance colon polyp formation. Nat. Med. 4, 1058-1061.
44. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. (1995). Expression of cyclooxygenase-1 and -2 in human CRC. Cancer Res. 55, 3785-3789.
45. Sarraf, P., Mueller, E., Jones, D., King, F.J., DeAngelo, D.J., Partridge, J.B., Holden, S.A., Chen, L.B., Singer, S., Fletcher, C., and Spiegelman, B.M. (1998). Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med. 4, 1046-1052.
46. Sarraf, P., Mueller, E., Smith, W.M., Wright, H.M., Kum, J.B., Aaltonen, LA., de la Chapelle, A., Spiegelman, B.M., and Eng, C. (1999). Loss-of-function mutations in PPAR γ associated with human colon cancer. Mol. Cell 3, 799-804.
47. Schmidt, A., Endo, N., Rutledge, S.J., Vogel, R., Shinar, D., and Rodan, G.A. (1992). Identification of a new member of the steroid hormone receptor super-family that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6, 1634-1641.
48. Shattuck-Brandt, R.L., Lamps, L.W., Heppner Goss, K.J., DuBois, R.N., and Matrisian, LM. (1999). Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol. Carcinog. 24, 177-187.
49. Shift, S.J., Qiao, L., Tsai, L.L., and Rigas, B. (1995). Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96, 491-503.
50. Simmons, D.L., Bolting, R.M., Robertson, P.M., Madsen, M.L., and Vane, J.R. (1999). Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 96, 3275-3280.
51. Smalley, W.E., and DuBois, R.N. (1997). CRC and nonsteroidal antiinflammatory drugs. Adv. Pharmacol. 39, 1-20.
52. Su, L.K., Vogelstein, B., and Kinzler, K.W. (1993). Association of the APC tumor suppressor protein with catenins. Science 262, 1734-1737.
53. Tetsu, O., and McCormick, F. (1999). β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
54. Thun, M.J. (1997). Aspirin and gastrointestinal cancer. Adv. Exp. Med. Biol. 400A, 395-402.
55. Tsujii, M., and Dubois, R.N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
56. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L., and Green, S. (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EM BO J. 11, 433-439.
57. Vanden Heuvel, J.P. (1999). Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis. J. Nutr. 729, 575-580.
58. Willett, W.C., Stampfer, M.J., Colditz, G.A., Rosner, B.A., and Speizer, F.E. (1990). Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med. 323, 1664-1672.
59. Yu, K., Bayona, W., Kallen, C.B., Harding, H.P., Ravera, C.P., McMahon, G., Brown, M., and Lazar, M.A. (1995). Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975-23983.
60. Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kiinzler, K.W., Vogelstein, B., and and Kern, S.E. (1998). Human SmadS and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617.
61. Zhang, X., Moiham, S.G., Langenbach, R., and Young, D.A. (1999). Malignant transformation and antineoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J. Exp. Med. 190, 451-460.